whether aggressive blood-glucose lowering is HARMFUL in some type 2 diabetes patients
Experts are now debating whether aggressive blood-glucose lowering is HARMFUL in some type 2 diabetes patients.
This comes from early results of the big "ACCORD" trial.
It was expected to show that intensive control of glucose, lipids, or blood pressure would IMPROVE outcomes in type 2 diabetes patients at high cardiovascular risk.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote